Cannabidiolic Acid (CBD-A, CBDA), an acid with the carboxylic group (COOH) attached, is a precursor to Cannabidiol. It is only when the carboxyl group is removed through decarboxylation that CBDA converts to CBD.

Cannabidiol (CBD), an isomer of THC, is a non-psychoactive cannabinoid with sedative, anti-anxiety, anti-psychotic qualities known to relieve convulsion, fight inflammation, assuage nausea, and may even inhibit the growth of some types of cancer cells.

Delta-9-Tetrahydrocannabinol Carboxylic Acid(Δ9-THC-A, THCA), an acid with the carboxylic group (COOH) attached. In its acid form, THC is not very active. It is only when the carboxyl group is removed through decarboxylation that THC becomes psychoactive.

Delta-9-Tetrahydrocannabinol (Δ9-THC, THC) is the primary psychoactive component of the plant. It appears to ease moderate pain (analgesic) and to be neuroprotective.  THC has been the most widely studied Cannabinoid, and its precise measurement is an integral part of medical cannabis potency testing.

Delta-8-Tetrahydrocannabinol (Δ8-THC) is an analogue of delta-9-tetrahydrocannabinol (Δ9-THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties. Delta-8-tetrahydrocannabinol exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol, the primary form of THC found in cannabis.

Cannabinol (CBN), a metabolite of THC, is a cannabinoid derived from the degradation of THC over time and, when properly measured, can help determine both the freshness of samples and their level of psycho-activity. CBN offers a mild sedative effect for patients with various degrees of insomnia.

Cannabigerol (CBG) is a non-psychoactive cannabinoid, which has been shown to relieve intraocular pressure, which may be of benefit in the treatment of glaucoma. It can also be used to treat inflammatory bowel disease.